IGM Biosciences, Inc. (IGMS)
USD 1.15
(8.02%)
USD 1.15
(8.02%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -211.66 Million USD | 35.52% |
| 2022 | -9.53 Million USD | -23.42% |
| 2021 | -7.72 Million USD | -116.0% |
| 2020 | -3.57 Million USD | -53.28% |
| 2019 | -2.33 Million USD | -739.21% |
| 2018 | -278 Thousand USD | -72.67% |
| 2017 | -161 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -1.02 Million USD | 39.13% |
| 2024 Q1 | -1.67 Million USD | -9.74% |
| 2023 Q1 | -2.46 Million USD | 13.51% |
| 2023 Q2 | -3.07 Million USD | -24.54% |
| 2023 Q4 | -1.53 Million USD | 12.57% |
| 2023 FY | -6.14 Million USD | 35.52% |
| 2023 Q3 | -1.75 Million USD | 43.0% |
| 2022 Q4 | -2.85 Million USD | -24.4% |
| 2022 Q3 | -2.29 Million USD | -5.72% |
| 2022 Q2 | -2.16 Million USD | 2.61% |
| 2022 FY | -9.53 Million USD | -23.42% |
| 2022 Q1 | -2.22 Million USD | -2.16% |
| 2021 Q4 | -2.17 Million USD | -11.52% |
| 2021 FY | -7.72 Million USD | -116.0% |
| 2021 Q3 | -1.95 Million USD | 13.12% |
| 2021 Q2 | -2.24 Million USD | -67.14% |
| 2021 Q1 | -1.34 Million USD | 0.0% |
| 2020 FY | -3.57 Million USD | -53.28% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | -2.33 Million USD | -739.21% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | -278 Thousand USD | -72.67% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2017 FY | -161 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -77.59 Million USD | -172.765% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -1484.537% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -4311.421% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -42920.325% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 41199.029% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -118.319% |
| Agenus Inc. | 139.61 Million USD | 251.603% |
| Fortress Biotech, Inc. | 57.85 Million USD | 465.858% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -147603.087% |
| Novavax, Inc. | 639.93 Million USD | 133.075% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -31776.506% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 1104.986% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -5632.936% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 826.63% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 275.689% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 113.944% |
| AlloVir, Inc. | -398 Thousand USD | -53080.905% |
| Aptorum Group Limited | -1.11 Million USD | -18888.273% |
| Ardelyx, Inc. | 106.66 Million USD | 298.442% |
| Bicycle Therapeutics plc | -129.52 Million USD | -63.419% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 176483.333% |
| Chimerix, Inc. | 324 Thousand USD | 65427.16% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -579.101% |
| CRISPR Therapeutics AG | 240.95 Million USD | 187.842% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 2789.112% |
| Precision BioSciences, Inc. | 40.47 Million USD | 622.979% |
| Dyadic International, Inc. | 922.95 Thousand USD | 23032.813% |
| Elevation Oncology, Inc. | -39 Thousand USD | -542617.949% |
| Fortress Biotech, Inc. | 57.85 Million USD | 465.858% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Alkermes plc | 1.37 Billion USD | 115.397% |
| Immix Biopharma, Inc. | -5468.00 USD | -3870785.15% |
| Innoviva, Inc. | 261.06 Million USD | 181.076% |
| IO Biotech, Inc. | -756 Thousand USD | -27897.354% |
| Jaguar Health, Inc. | 7.72 Million USD | 2840.29% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 276.747% |
| ContextLogic Inc. | 59 Million USD | 458.746% |
| AbCellera Biologics Inc. | 38.02 Million USD | 656.634% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -120957.177% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -384736.364% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 187.922% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -40063.188% |
| MEI Pharma, Inc. | 49.32 Million USD | 529.096% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 26491.521% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 828.48% |
| NextCure, Inc. | -3.68 Million USD | -5645.385% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 1376.829% |
| ChromaDex Corporation | 50.78 Million USD | 516.818% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -99.448% |
| Incyte Corporation | 3.44 Billion USD | 106.152% |
| Opthea Limited | 21.72 Thousand USD | 974593.554% |
| MiMedx Group, Inc. | 266.84 Million USD | 179.32% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -478898.823% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 1082.409% |
| Psyence Biomedical Ltd. | -240.00 USD | -88191566.667% |
| Vaxcyte, Inc. | -75 Million USD | -182.213% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -369121.645% |
| Pharming Group N.V. | 220.1 Million USD | 196.164% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 21077.205% |
| Onconetix, Inc. | -1.12 Million USD | -18678.085% |
| Acelyrin, Inc. | -115 Thousand USD | -183952.174% |
| PureTech Health plc | -1.6 Million USD | -13103.993% |
| Pyxis Oncology, Inc. | -2 Million USD | -10483.0% |
| Avidity Biosciences, Inc. | -181.4 Million USD | -16.676% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -40860.162% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -178529.601% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 292.818% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 1211.485% |
| Seer, Inc. | 7.02 Million USD | 3112.096% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -366.983% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -862.66% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -2105760.113% |
| Summit Therapeutics Inc. | -2.05 Million USD | -10224.878% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -36968.301% |
| Senti Biosciences, Inc. | -2.68 Million USD | -7788.93% |
| ImmuCell Corporation | 4.39 Million USD | 4914.521% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -115.502% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -351.888% |
| Precigen, Inc. | 106 Thousand USD | 199779.245% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -4233100.0% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -630.668% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 5324.883% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 256.473% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -5269.29% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 820.25% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 4934.628% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 42773.387% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 50019.811% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -258021.951% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 303.326% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -115.621% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -91132.759% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 34855.337% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 167.478% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 8322.999% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -417046.236% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -2881.967% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -44502.725% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -2035092.308% |
| Soligenix, Inc. | 97.31 Thousand USD | 217608.812% |
| Century Therapeutics, Inc. | -10.8 Million USD | -1858.183% |
| Kura Oncology, Inc. | -849 Thousand USD | -24830.506% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -215.421% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -143886.395% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 313.714% |
| Autolus Therapeutics plc | -4.86 Million USD | -4248.88% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 611.429% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -125888.095% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 323.452% |
| GRI Bio, Inc. | 10.84 Million USD | 2052.403% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 8433.117% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -2336.514% |
| INmune Bio, Inc. | 155 Thousand USD | 136654.839% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 441.723% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -13951.734% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -32540.712% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -722930.676% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 52751.741% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -10504.208% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -67523.003% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 324.071% |
| Verastem, Inc. | -62 Thousand USD | -341287.097% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 8792.402% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -80995.785% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 7092.402% |
| Histogen Inc. | 3.76 Million USD | 5715.813% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 36835.112% |
| Surrozen, Inc. | -27.23 Million USD | -677.304% |
| Organovo Holdings, Inc. | -5.38 Million USD | -3827.63% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -17466.895% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -725.282% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 1155.556% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -10689798.99% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 3589.041% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -315193.977% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 236.739% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 145271.468% |
| Apollomics, Inc. | 127 Thousand USD | 166761.417% |
| Amarin Corporation plc | 165.54 Million USD | 227.86% |
| Mesoblast Limited | -9.81 Million USD | -2056.495% |
| Turnstone Biologics Corp. | 16.5 Million USD | 1382.322% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -91.567% |
| Synaptogenix, Inc. | -6347.00 USD | -3334703.844% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -414919.608% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 231.168% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 112.042% |
| Better Therapeutics, Inc. | -2.72 Million USD | -7655.955% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -88.711% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 162.606% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1855264.656% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -3281.15% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -19002.888% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 2992.32% |
| Insmed Incorporated | 239.63 Million USD | 188.326% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 6015.595% |
| OmniAb, Inc. | 14.66 Million USD | 1543.104% |
| Alector, Inc. | -95.05 Million USD | -122.676% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 268.491% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -386.989% |
| Zai Lab Limited | 170.9 Million USD | 223.848% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 358.51% |
| Aura Biosciences, Inc. | -1.29 Million USD | -16244.402% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 162915.385% |
| Immunic, Inc. | -111 Thousand USD | -190584.685% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 1435.057% |
| Veracyte, Inc. | 248.14 Million USD | 185.296% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 96.972% |
| FibroGen, Inc. | 128.9 Million USD | 264.2% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -37528268.794% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -1714.195% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 106.228% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 54511.311% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 159.565% |
| TG Therapeutics, Inc. | 219.1 Million USD | 196.601% |
| Galecto, Inc. | -830 Thousand USD | -25401.205% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -15182.31% |
| Fortrea Holdings Inc. | 424 Million USD | 149.92% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -145.639% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -37229.806% |
| XBiotech Inc. | -1.74 Million USD | -12036.468% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -19002.888% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -355.467% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -180.218% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 388.353% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 1359.656% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 154.406% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -326.33% |
| Vaxxinity, Inc. | -2.23 Million USD | -9374.485% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 164.777% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -1769.154% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 965.65% |
| NexImmune, Inc. | -1.02 Million USD | -20550.32% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 3919729.63% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -2878.754% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 101.873% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -316628.269% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -5860.574% |
| Ainos, Inc. | -253.73 Thousand USD | -83318.397% |
| Pluri Inc. | 322 Thousand USD | 65832.919% |
| Prothena Corporation plc | -129.2 Million USD | -63.822% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 519.761% |
| Celularity Inc. | 6.75 Million USD | 3233.383% |
| Rallybio Corporation | -150 Thousand USD | -141006.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -549.124% |
| MeiraGTx Holdings plc | 287 Thousand USD | 73849.129% |
| Omeros Corporation | -69.77 Million USD | -203.329% |
| Humacyte, Inc. | -76.55 Million USD | -176.499% |
| Immunocore Holdings plc | 248.39 Million USD | 185.212% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -1295.346% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 439.297% |
| Blueprint Medicines Corporation | 236.58 Million USD | 189.465% |
| CalciMedica, Inc. | -58 Thousand USD | -364831.034% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -14742.917% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -7342.335% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -585.761% |
| Pulmatrix, Inc. | -8.22 Million USD | -2474.939% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -17990.598% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -52947.619% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 46.925% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 7725.78% |
| Cytokinetics, Incorporated | -322.59 Million USD | 34.388% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 24651.534% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -61970.381% |
| Vor Biopharma Inc. | -3.49 Million USD | -5961.283% |
| Roivant Sciences Ltd. | 109.23 Million USD | 293.766% |
| Evogene Ltd. | 1.39 Million USD | 15229.378% |
| ProKidney Corp. | -3.16 Million USD | -6579.079% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -382.009% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 3186.773% |
| CorMedix Inc. | -205.56 Thousand USD | -102866.502% |
| BioLineRx Ltd. | 1.1 Million USD | 19202.888% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -169.045% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -641293.939% |
| Atai Life Sciences N.V. | -5000.00 USD | -4233100.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -173592.546% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -220379.167% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -15138.301% |
| Sagimet Biosciences Inc. | 2 Million USD | 10683.0% |
| MediciNova, Inc. | 979.7 Thousand USD | 21704.463% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -151.023% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -223748.554% |
| GeoVax Labs, Inc. | -20.72 Million USD | -921.487% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 186.556% |
| Biomea Fusion, Inc. | -4.2 Million USD | -4938.324% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 124.264% |
| Mereo BioPharma Group plc | 7.42 Million USD | 2950.256% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -68177.419% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -1763733.333% |
| Absci Corporation | -41.84 Million USD | -405.771% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -4233100.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -177.14% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -8500.569% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 199.029% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -22393.092% |
| Allakos Inc. | -6.14 Million USD | -3346.67% |
| Imunon, Inc. | -720 Thousand USD | -29297.018% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -206.771% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 144.476% |
| BioAtla, Inc. | -103.73 Million USD | -104.047% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1855264.656% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -118810.112% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 12.832% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -67957.878% |
| XOMA Corporation | 3.86 Million USD | 5581.999% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -202.005% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 1530.715% |
| aTyr Pharma, Inc. | -2.38 Million USD | -8763.484% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 1798.716% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -729762.069% |
| Viridian Therapeutics, Inc. | -1 Million USD | -20898.016% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 1628153946.154% |
| Akari Therapeutics, Plc | -4000.00 USD | -5291400.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 133.233% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 108806.371% |
| UroGen Pharma Ltd. | 73.35 Million USD | 388.554% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -692.912% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 1823183.549% |
| Orgenesis Inc. | -5.72 Million USD | -3597.118% |
| Entera Bio Ltd. | -56 Thousand USD | -377864.286% |
| GH Research PLC | -315 Thousand USD | -67093.651% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -111889.418% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -40216.19% |
| Xencor, Inc. | -85.26 Million USD | -148.252% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -95683.724% |
| Replimune Group, Inc. | -2.65 Million USD | -7872.128% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -21039.871% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 219.014% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 108806.371% |
| Portage Biotech Inc. | -54 Thousand USD | -391862.963% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -223748.554% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -56043.236% |
| OncoCyte Corporation | 413 Thousand USD | 51349.395% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -4708687.542% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -95342242.342% |
| Purple Biotech Ltd. | -196 Thousand USD | -107889.796% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 2460.169% |
| scPharmaceuticals Inc. | 9.78 Million USD | 2263.77% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -1926.432% |
| HilleVax, Inc. | -2.15 Million USD | -9717.254% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -218106.186% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -1410590.483% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -31585.629% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -920160.87% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -2819717.323% |
| Savara Inc. | -44.26 Million USD | -378.198% |
| Curis, Inc. | 9.81 Million USD | 2257.374% |
| Daré Bioscience, Inc. | 2.76 Million USD | 7742.474% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -169515.668% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -12141.758% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -92733.333% |
| BeiGene, Ltd. | 2.07 Billion USD | 110.182% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -7470.371% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 47.041% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 473.377% |
| Erasca, Inc. | -3.73 Million USD | -5571.49% |
| bluebird bio, Inc. | -4.03 Million USD | -5152.109% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -749988.596% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 111.114% |
| DBV Technologies S.A. | 15.72 Million USD | 1445.753% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -749988.596% |
| Moderna, Inc. | 2.15 Billion USD | 109.822% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -23032.24% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 2743.767% |
| Molecular Templates, Inc. | 50.39 Million USD | 520.002% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -39388.806% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 258.206% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -3301.8% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -437.986% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -90.465% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -5799.108% |
| MacroGenics, Inc. | 50.52 Million USD | 518.905% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -3370.974% |
| Prime Medicine, Inc. | -147.9 Million USD | -43.105% |
| Aditxt, Inc. | -111.66 Thousand USD | -189457.586% |
| Adagene Inc. | 18.11 Million USD | 1268.65% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 43472.951% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 250.968% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 234.101% |
| SciSparc Ltd. | 2.19 Million USD | 9738.434% |
| Vericel Corporation | 135.57 Million USD | 256.119% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -844883.832% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -683070.873% |
| Generation Bio Co. | -73.91 Million USD | -186.371% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -48334.783% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 487.521% |
| Invivyd, Inc. | -2.02 Million USD | -10336.884% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 29.644% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -204524.993% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 319.637% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 315.347% |
| ADMA Biologics, Inc. | 88.21 Million USD | 339.928% |
| Clene Inc. | 533 Thousand USD | 39811.069% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 977.923% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -22017.032% |
| GeoVax Labs, Inc. | -20.72 Million USD | -921.487% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 10746.881% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -108825.667% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 524.977% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -2884.49% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -25218.182% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 353.743% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 289601.04% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 498.142% |
| Verve Therapeutics, Inc. | -173.18 Million USD | -22.214% |
| Trevena, Inc. | 1.45 Million USD | 14647.079% |
| Surrozen, Inc. | -27.23 Million USD | -677.304% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -59860.34% |
| Cingulate Inc. | -582.91 Thousand USD | -36210.424% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -682674.194% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -974.471% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -2795936.988% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -23924.972% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 131.094% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -21323.077% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -375570.015% |
| Kronos Bio, Inc. | 1.37 Million USD | 15527.114% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -294.402% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -72386.301% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -43245.061% |
| ImmunityBio, Inc. | -17.89 Million USD | -1083.119% |
| Korro Bio, Inc. | -3.63 Million USD | -5730.854% |
| Kineta, Inc. | 5.43 Million USD | 3995.822% |
| BioVie Inc. | -229.37 Thousand USD | -92176.035% |
| Codexis, Inc. | 57.33 Million USD | 469.17% |
| Celularity Inc. | 6.75 Million USD | 3233.383% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 5374.358% |
| Celcuity Inc. | -142.77 Thousand USD | -148150.357% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 418483.08% |
| Cibus, Inc. | 1.42 Million USD | 14984.669% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -56493.583% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -823.513% |
| IN8bio, Inc. | -2.5 Million USD | -8363.015% |
| Kodiak Sciences Inc. | -25.94 Million USD | -715.74% |
| Annexon, Inc. | -3.26 Million USD | -6378.727% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -10255.186% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -407.128% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 33171.875% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 127.188% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 222.379% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -11040.0% |
| Arcellx, Inc. | 108.27 Million USD | 295.477% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -553.897% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 367.234% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -900.662% |
| Moolec Science SA | -143.3 Thousand USD | -147598.964% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -400.165% |
| Geron Corporation | -123.5 Million USD | -71.38% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 6539.306% |
| Royalty Pharma plc | 1.79 Billion USD | 111.799% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -201.983% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -5859811.406% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 91572.875% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -89.976% |
| Humacyte, Inc. | -76.55 Million USD | -176.499% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -22199.389% |
| 89bio, Inc. | -273 Thousand USD | -77431.136% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -16738.504% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -24859.906% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -171981.301% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 19015.103% |
| Notable Labs, Ltd. | 113 Thousand USD | 187409.735% |
| Liquidia Corporation | 14.6 Million USD | 1549.726% |
| Mustang Bio, Inc. | -2.22 Million USD | -9412.809% |
| Immunovant, Inc. | -231 Thousand USD | -91527.706% |
| Quantum-Si incorporated | 488 Thousand USD | 43472.951% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -280.964% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -705433.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 11467.347% |
| Acasti Pharma Inc. | -11 Thousand USD | -1924081.818% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -103342.04% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -32540.712% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | -26.355% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 18755.361% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -55453.806% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -10710.01% |
| PepGen Inc. | -1.18 Million USD | -17776.689% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -166561.417% |
| United Therapeutics Corporation | 2.07 Billion USD | 110.225% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -824.401% |
| Solid Biosciences Inc. | -76.56 Million USD | -176.452% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -256199.723% |
| Immuneering Corporation | -764.13 Thousand USD | -27599.185% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 319519.293% |
| Belite Bio, Inc | -399 Thousand USD | -52947.619% |
| XOMA Corporation | 3.86 Million USD | 5581.999% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -956.398% |
| Bionomics Limited | -434.44 Thousand USD | -48619.182% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -19607.635% |
| uniQure N.V. | 2.21 Million USD | 9655.756% |
| Cassava Sciences, Inc. | -89.42 Million USD | -136.695% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -129.893% |
| Forte Biosciences, Inc. | -9000.00 USD | -2351677.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -25248.503% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -48334.783% |
| Altimmune, Inc. | -65.37 Million USD | -223.773% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 158.465% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -19607.635% |
| Compugen Ltd. | 31.45 Million USD | 772.898% |
| Peak Bio, Inc. | 367.76 Thousand USD | 57652.431% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 963.355% |
| Benitec Biopharma Inc. | 108 Thousand USD | 196081.481% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -271258.974% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -17494.347% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -11516.905% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -177765.546% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -17494.347% |
| Instil Bio, Inc. | -4.75 Million USD | -4350.378% |
| argenx SE | 1.1 Billion USD | 119.095% |
| Immunome, Inc. | -8.9 Million USD | -2276.333% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -11098.942% |
| Verona Pharma plc | -679.62 Thousand USD | -31043.691% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -120848.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | -8774.633% |
| CervoMed Inc. | -1.29 Million USD | -16261.749% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -8693.519% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -4330.814% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 8665.763% |
| Moolec Science SA | -143.3 Thousand USD | -147598.964% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -51773.637% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -7822.807% |
| AnaptysBio, Inc. | 14.78 Million USD | 1531.973% |
| Design Therapeutics, Inc. | -537 Thousand USD | -39315.27% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -49469.087% |
| NeurAxis, Inc. | 2.15 Million USD | 9914.05% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 9963.001% |
| Lumos Pharma, Inc. | 2 Million USD | 10646.089% |
| Achilles Therapeutics plc | -4.73 Million USD | -4373.643% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -120848.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -200193.352% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 768.567% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 24651.534% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -20409.69% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -364.697% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 492332.558% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -25649.392% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -1608503.131% |
| Palisade Bio, Inc. | 246 Thousand USD | 86140.65% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -641293.939% |
| Beam Therapeutics Inc. | -59.67 Million USD | -254.706% |
| Neurogene Inc. | -3.26 Million USD | -6388.657% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 251.907% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 629.15% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -71165.993% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -5155.974% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -2112.628% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 1603.267% |
| Athira Pharma, Inc. | -969 Thousand USD | -21743.137% |
| Vaccinex, Inc. | -16 Million USD | -1222.544% |
| HCW Biologics Inc. | -574.82 Thousand USD | -36721.705% |
| XOMA Corporation | 3.86 Million USD | 5581.999% |
| Nektar Therapeutics | 53.47 Million USD | 495.789% |
| Arvinas, Inc. | 71.8 Million USD | 394.791% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -153.603% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -237.172% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -65632.919% |
| Rezolute, Inc. | -36 Thousand USD | -587844.444% |
| Clene Inc. | 533 Thousand USD | 39811.069% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -16484323.676% |
| BeyondSpring Inc. | 1.75 Million USD | 12187.95% |
| Synlogic, Inc. | -1.92 Million USD | -10901.04% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -571954.054% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -3242.704% |
| Peak Bio, Inc. | 367.76 Thousand USD | 57652.431% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -1016.174% |
| Krystal Biotech, Inc. | 47.6 Million USD | 544.617% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 250.017% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 4312.139% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -8074.666% |
| MannKind Corporation | 136.19 Million USD | 255.414% |
| Ikena Oncology, Inc. | -50.49 Million USD | -319.195% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 294.515% |
| Gossamer Bio, Inc. | -4.38 Million USD | -4726.91% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -83892.063% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -4233100.0% |
| Legend Biotech Corporation | 140.92 Million USD | 250.189% |
| Mural Oncology plc | -2.56 Million USD | -8145.423% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -38313.793% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -211560.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 1119.852% |
| REGENXBIO Inc. | 53.02 Million USD | 499.14% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -3851.127% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -109924.691% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -12120.554% |
| Vaxart, Inc. | -60.76 Million USD | -248.337% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -80446.465% |
| Cellectis S.A. | 18 Thousand USD | 1175988.889% |
| Longeveron Inc. | 221 Thousand USD | 95873.756% |
| Repare Therapeutics Inc. | -80.07 Million USD | -164.344% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 119.365% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -16257.032% |
| Revolution Medicines, Inc. | -399.66 Million USD | 47.041% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -604642.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 432059.184% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 102.459% |
| Denali Therapeutics Inc. | -93.34 Million USD | -126.75% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -844883.832% |
| Veru Inc. | 7.56 Million USD | 2897.542% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -140072.185% |
| Cingulate Inc. | -582.91 Thousand USD | -36210.424% |
| Passage Bio, Inc. | -3.72 Million USD | -5588.256% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -1757289.572% |
| Exicure, Inc. | -1.42 Million USD | -14774.209% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -55163.708% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 7930.559% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -41185.415% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 410.689% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -141377.337% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -257.498% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 54232.992% |
| OmniAb, Inc. | 14.66 Million USD | 1543.104% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 1158.671% |
| Lipocine Inc. | -2.85 Million USD | -7324.536% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -11384.536% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -3610.079% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -13951.734% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 381.029% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -325530.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 351.091% |
| Ocugen, Inc. | -33.53 Million USD | -531.124% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -6593.865% |
| Q32 Bio Inc. | 578 Thousand USD | 36719.377% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -79771.698% |
| Alumis Inc. Common Stock | -1.28 Million USD | -16384.424% |
| Equillium, Inc. | 35.95 Million USD | 688.631% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -12299.531% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 42374.591% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -5119880.648% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -81622.008% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 50171.917% |
| Dominari Holdings Inc. | 2.03 Million USD | 10480.579% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -115264.281% |
| vTv Therapeutics Inc. | -13.59 Million USD | -1456.896% |
| Bio-Techne Corporation | 773.07 Million USD | 127.379% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 1322.126% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 145.935% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -18006.074% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -782.652% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1909.524% |
| Nkarta, Inc. | -5.86 Million USD | -3506.407% |
| BioCardia, Inc. | -7.24 Million USD | -2819.851% |
| Iterum Therapeutics plc | -1.75 Million USD | -11994.857% |